Why it was recalled
Subpotent Drug
Product description
Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.
Lot numbers, UPCs & expiration codes
Lot #: 69001A
Where it was sold
OH
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-164-2013
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jan 7, 2013
- FDA report date
- Feb 20, 2013
- Quantity
- 1,185 Bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- West-ward Pharmaceutical Corp.
Original FDA data
Every field from FDA enforcement report D-164-2013, exactly as published.
Show all FDA fields
- City
- Eatontown
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 64108
- Address
- 465 Industrial Way W
- Code information
- Lot #: 69001A
- Postal code
- 07724-2209
- Report date
- Feb 20, 2013
- Product type
- Drugs
- Recall number
- D-164-2013
- Classification
- Class III
- Recalling firm
- West-ward Pharmaceutical Corp.
- Product quantity
- 1,185 Bottles
- Termination date
- May 16, 2014
- Reason for recall
- Subpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.
- Distribution pattern
- OH
- Recall initiation date
- Jan 7, 2013
- Initial firm notification
- Letter
- Center classification date
- Feb 12, 2013